Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Chemir Acquires Lycoming Analytical Laboratories, Creates New Division: Chemir Pharma Services

By Pharmaceutical Processing | July 24, 2003

Chemir has announced the acquisition of Lycoming Analytical Laboratories in central Pennsylvania, a contract laboratory specializing in providing quality control (QC) testing to the pharmaceutical industry. The new company, Chemir Pharma Services, combines the capabilities of the Pennsylvania facility with the services of Chemir’s St. Louis location.

Chemir Pharma Services offers complete CMC solutions for pharmaceutical development. Core services include synthetic chemistry, characterization of drug substance and packaging systems, QC release of API’s and excipients, methods development and validation, preformulation evaluations and stability studies. “We’re excited about this acquisition,” says Phil Meeks, CEO of Chemir Pharma Services. “This acquisition will integrate QC capabilities into Chemir’s core research and development expertise. This combination of services offers our customers a wide range of CMC support activities, enhancing their abilities to bring new medicines to the marketplace.”

Dr. Wayne Way, who will assume the responsibility as President, will head the Pennsylvania facility. Dr. Way has spent the previous six years as President of the St. Louis, MO operations where he was an integral part of the growth and success of Chemir.

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards